ArticlemedRxiv : the preprint server for health sciences2026
Adverse Childhood Experiences and Growth Outcomes in Childhood: A Longitudinal EHR-Based Study.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Adverse childhood experiences (ACEs) are among the strongest risk factors for long-term mental and physical health complications, yet their impact on childhood biological development remains incompletely understood. In this study, we leverage longitudinal electronic health record (EHR) data from over 400,000 pediatric patients to examine the relationship between clinical ACE documentation identified from a Natural Language Processing (NLP) algorithm and growth trajectories across childhood and adolescence. In this cohort, ACE documentation was associated with consistently lower height Z-scores, reduced final attained height, and earlier timing of peak growth velocity. Differences in height became significant approximately two years before ACE documentation, suggesting that growth disruption precedes formal clinical recognition. Importantly, the magnitude of growth disruption depended on the child's age at ACE documentation, with earlier ACE associated with the largest alterations in height and growth timing. These findings support a model in which early stress impacts childhood growth during sensitive periods and may represent a clinically accessible biomarker of the negative health consequences of ACEs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.